Entera Bio

Entera Bio Altman Z-Score

The Altman Z-Score of Entera Bio (ENTX) as of Nov 22, 2026 is -2.03. In the previous year, Altman Z-Score was 4.66 — a change of -143.55% (lower).

Altman Z-Score

-2.03

YoY

-143.55%

Last updated:

Altman Z-Score of Entera Bio is 2025 -2.03 . Altman Z-Score of Entera Bio was 2024 4.66 . It decreases by -143.55% lower compared to the previous year.

The Entera Bio Altman Z-Score history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Altman Z-Score
Date
Altman Z-Score
Jan 1, 2018
2.03 USD
Jan 1, 2019
-0.68 USD
Jan 1, 2020
0.95 USD
Jan 1, 2021
3.60 USD
Jan 1, 2022
10.40 USD
Jan 1, 2023
8.82 USD
Jan 1, 2024
4.66 USD
Jan 1, 2025
-2.03 USD
The Entera Bio Altman Z-Score history
YEARAltman Z-ScoreYoY
-2.03-143.55%
4.66-47.15%
8.82-15.24%
10.40+189.04%
3.60+280.36%
0.95-239.55%
-0.68-133.32%
2.03-336.75%
-0.86-90.01%
-8.60-52.98%
-18.29—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Entera Bio Stock analysis

What does Entera Bio do? Entera Bio Ltd is an emerging biotechnology company focused on developing oral medications to treat unmet medical needs. The company was founded in 2010 and is headquartered in Jerusalem, Israel. Its history began with the discovery of the "EnteraGam" molecule in the intestinal cells of breastfed infants, which helps them fight infections. This led to the development of EnteraGam for the treatment of various autoimmune diseases. The company's business model is based on developing oral formulations for existing drugs and discovering and developing new molecules. Its focus areas are osteoporosis, hypoparathyroidism, chronic kidney disease, and autoimmune diseases. Entera Bio is divided into three business divisions: the Oral Protein Delivery Platform, the Oral Parathyroid Hormone (PTH) Platform, and the Collagen-based Platform for Wound Healing. Its products include EB611, a candidate for hypoparathyroidism treatment, EB613 for osteoporosis treatment, and EB612 for chronic kidney disease. These products have potential to improve the lives of millions of patients worldwide. Entera Bio is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Entera Bio stock

Altman Z-Score of Entera Bio is -2.03 in 2025.

On Eulerpool you can find the complete historical development of Altman Z-Score Entera Bio since 2006 – with annual values, charts, and detailed analysis.

The Altman Z-Score predicts bankruptcy probability using five financial ratios. Scores above 3.0 indicate safety, below 1.8 suggests distress risk.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Entera Bio

All Key Metrics — Entera Bio